Table 2 Spearman’s correlation test for stratification of prognostic subtypes according to the MLVD
From: Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
MLVD | n (%) | r (95% CI) | P (two-paired) | P value summary |
|---|---|---|---|---|
4 to 4 | 1 (1.3) | NA | NA | NA |
4 to 5 | 7 (8.9) | 0.2041 (NA) | 0.5714 | NS |
4 to 6 | 11 (13.9) | −0.4077 (−0.8166 to 0.2736) | 0.1013 | NS |
4 to 7 | 16 (20.3) | −0.4604 (−0.7847 to 0.0619) | 0.0456 | * |
4 to 8 | 19 (24.1) | −0.5844 (− 0.8255 to − 0.1631) | 0.0086 | ** |
4 to 9 | 23 (29.1) | −0.6729 (− 0.8531 to − 0.3494) | 0.0004 | *** |
4 to 10 | 26 (32.9) | −0.6035 (− 0.8074 to − 0.2709) | 0.0011 | ** |
4 to 11 | 27 (34.2) | −0.6182 (− 0.8124 to − 0.3005) | 0.0006 | *** |
4 to 12 | 32 (40.5) | −0.6589 (− 0.8229 to − 0.3936) | < 0.0001 | **** |
4 to 13 | 37 (46.8) | −0.6647 (− 0.8169 to − 0.4260) | < 0.0001 | **** |
4 to 14 | 39 (49.4) | −0.6619 (− 0.8119 to − 0.4299) | <  0.0001 | **** |
4 to 15 | 44 (55.7) | − 0.6436 (− 0.7930 to − 0.4212) | <  0.0001 | **** |
4 to 16 | 48 (60.8) | − 0.6377 (− 0.7838 to − 0.4248) | < 0.0001 | **** |
4 to 17 | 50 (63.3) | − 0.6220 (− 0.7709 to − 0.4085) | <  0.0001 | **** |
4 to 18 | 56 (70.9) | − 0.6630 (− 0.7915 to − 0.4784) | < 0.0001 | **** |
4 to 19 | 60 (75.9) | −0.6456 (− 0.7759 to − 0.4624) | < 0.0001 | **** |
4 to 20 | 68 (86.1) | −0.6752 (− 0.7897 to − 0.5152) | < 0.0001 | **** |
4 to 21 | 69 (87.3) | −0.6811 (− 0.7931 to − 0.5247) | < 0.0001 | **** |
4 to 22 | 72 (91.1) | −0.6789 (− 0.7895 to − 0.5256) | < 0.0001 | **** |
4 to 23 | 76 (96.2) | −0.6149 (− 0.7411 to − 0.4466) | < 0.0001 | **** |
4 to 24 | 76 (96.2) | −0.6149 (− 0.7411 to − 0.4466) | < 0.0001 | **** |
4 to 25 | 79 (100) | −0.5966 (− 0.7256 to − 0.4271) | < 0.0001 | **** |